Br Med J (Clin Res Ed) 1983; 286(6375):1391-1393.33. Tang AL, Davies DR, Wing AJ. «Remission of nephrotic syndrome in amyloidosis associated with a hypernephroma», Clin Nephrol 1989; 32(5):225-228.34. Keven K, Nergizoglu G, Ates K, Erekul S, Orhan D, Erturk S et al. «Remission of nephrotic syndrome after removal of localized Castleman\'s disease», Am J Kidney Dis 2000; 35(6):1207-1211.35. Perfetti V, Bellotti V, Maggi A, Arbustini E, De Benedetti F, Paulli M et al. «Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localized Castleman\'s disease», Am J Hematol 1994; 46(3):189-193.36. Alabi ZO, Ojo OS, Odesanmi WO. «Secondary amyloidosis in chronic osteomyelitis», Int Orthop 1991; 15(1):21-22.37. Berglund K, Keller C, Thysell H. «Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease», Ann Rheum Dis 1987; 46(10):757-762.38. Camussi G, Lupia E. «The future role of anti-tumour necrosis factor (TNF) products in the treatment of rheumatoid arthritis», Drugs 1998; 55(5):613-620.39. Charles P, Elliott MJ, Davis D, Potter A, Kalden JR, Antoni C et al. «Regulation of cytokines, cytokine inhibitors, and acute-phase proteins amyloidosis (AA-type) after excision of localized Castleman\'s disease», Am J Hematol 1994; 46(3):189-193.36. Alabi ZO, Ojo OS, Odesanmi WO. «Secondary amyloidosis in chronic osteomyelitis», Int Orthop 1991; 15(1):21-22.37. Berglund K, Keller C, Thysell H. «Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease», Ann Rheum Dis 1987; 46(10):757-762.38. Camussi G, Lupia E. «The future role of anti-tumour necrosis factor following anti-TNF-alpha therapy in rheumatoid arthritis», J Immunol 1999; 163(3):1521-1528.40. Goldfinger SE. «Colchicine for familial Mediterranean fever», N Engl J Med 1972; 287(25):1302.41. Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E et al. «A controlled trial of colchicine in preventing attacks of familial mediterranean fever», N Engl J Med 1974; 291(18):932-934.42. Dinarello CA, Wolff SM, Goldfinger SE, Dale DC, Alling DW. «Colchicine therapy for familial mediterranean fever. A double-blind trial», N Engl J Med 1974; 291(18):934-937.43. Ben Chetrit E, Levy M. «Colchicine prophylaxis in familial Mediterranean fever: reappraisal after 15 years», Semin Arthritis Rheum 1991; 20(4):241-246.44. Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. «Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever», N Engl J Med 1986; 314(16):1001-1005.45. Livneh A, Zemer D, Langevitz P, Laor A, Sohar E, Pras M. «Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome», Arthritis Rheum 1994; 37(12):1804-1811.

La respuesta correcta se infiere al leer atentamente el trabajo:

NOTABLES PROGRESOS EN EL TRATAMIENTO DE LA AMILOIDOSIS AA

Programa SIIC  de Eduación Médica Contínua (PEMC-SIIC)